Kevin P. Kerns

Array ( [id] => 5501683 [patent_doc_number] => 20090162371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Anti-IL-23 Antibodies, Compositions, Methods and Uses' [patent_app_type] => utility [patent_app_number] => 12/370872 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33692 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162371.pdf [firstpage_image] =>[orig_patent_app_number] => 12370872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473036 [patent_doc_number] => 20090246202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Human Endokine Alpha and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/370897 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 80769 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246202.pdf [firstpage_image] =>[orig_patent_app_number] => 12370897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162091 [patent_doc_number] => 07670789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-02 [patent_title] => 'Methods and devices for diagnosis of appendicitis' [patent_app_type] => utility [patent_app_number] => 12/369640 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 12690 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/670/07670789.pdf [firstpage_image] =>[orig_patent_app_number] => 12369640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5532979 [patent_doc_number] => 20090232767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'METHODS AND COMPOSITIONS BASED ON DIPHTHERIA TOXIN-INTERLEUKIN-3 CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/368048 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 50562 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232767.pdf [firstpage_image] =>[orig_patent_app_number] => 12368048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82605 [patent_doc_number] => 07740834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Murine zcytor17 ligand polypeptides' [patent_app_type] => utility [patent_app_number] => 12/362318 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 80493 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/740/07740834.pdf [firstpage_image] =>[orig_patent_app_number] => 12362318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5484940 [patent_doc_number] => 20090274705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'IL-13 BINDING AGENTS' [patent_app_type] => utility [patent_app_number] => 12/358111 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 38103 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274705.pdf [firstpage_image] =>[orig_patent_app_number] => 12358111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7539960 [patent_doc_number] => 08057802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Treatment methods for fibrosis related disorders' [patent_app_type] => utility [patent_app_number] => 12/343606 [patent_app_country] => US [patent_app_date] => 2008-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 12837 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/057/08057802.pdf [firstpage_image] =>[orig_patent_app_number] => 12343606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568926 [patent_doc_number] => 20100273215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => ' Secretion Yield of a Protein of Interest by in vivo Proteolytic Processing of a Multimeric Precursor' [patent_app_type] => utility [patent_app_number] => 12/808326 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9231 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273215.pdf [firstpage_image] =>[orig_patent_app_number] => 12808326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574992 [patent_doc_number] => 20090142353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Human Tumor Necrosis Factor Receptor TR17' [patent_app_type] => utility [patent_app_number] => 12/336051 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 128330 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142353.pdf [firstpage_image] =>[orig_patent_app_number] => 12336051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6144485 [patent_doc_number] => 20110130335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'THERAPEUTIC AGENT AND TEST AGENT FOR DISEASE WITH MYOCARDIAL NECROSIS' [patent_app_type] => utility [patent_app_number] => 13/054782 [patent_app_country] => US [patent_app_date] => 2008-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22230 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130335.pdf [firstpage_image] =>[orig_patent_app_number] => 13054782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284934 [patent_doc_number] => 20090098609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'IL-2 FUSION PROTEINS WITH MODULATED SELECTIVITY' [patent_app_type] => utility [patent_app_number] => 12/325599 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17940 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098609.pdf [firstpage_image] =>[orig_patent_app_number] => 12325599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8652643 [patent_doc_number] => 08372389 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Methods for the treatment of radiation or chemotherapy-induced tissue damage' [patent_app_type] => utility [patent_app_number] => 12/745049 [patent_app_country] => US [patent_app_date] => 2008-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11425 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12745049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379361 [patent_doc_number] => 20090191200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 Activity' [patent_app_type] => utility [patent_app_number] => 12/277030 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12492 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191200.pdf [firstpage_image] =>[orig_patent_app_number] => 12277030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469345 [patent_doc_number] => 08298523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Compositions containing interleukin-1 and peptides' [patent_app_type] => utility [patent_app_number] => 13/124272 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4932 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038363 [patent_doc_number] => 20110091412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'MUTANT INTERLEUKIN-2 (IL-2) POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/741552 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15753 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091412.pdf [firstpage_image] =>[orig_patent_app_number] => 12741552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608382 [patent_doc_number] => 07993637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'IL-11 muteins' [patent_app_type] => utility [patent_app_number] => 12/257565 [patent_app_country] => US [patent_app_date] => 2008-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12788 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993637.pdf [firstpage_image] =>[orig_patent_app_number] => 12257565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276880 [patent_doc_number] => 20100256337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'METHOD FOR PURIFYING AN FC-CONTAINING PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/738515 [patent_app_country] => US [patent_app_date] => 2008-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13349 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256337.pdf [firstpage_image] =>[orig_patent_app_number] => 12738515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5953834 [patent_doc_number] => 20110034383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'CXCL12 GAMMA A CHEMOKINE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/682943 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17604 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034383.pdf [firstpage_image] =>[orig_patent_app_number] => 12682943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5338163 [patent_doc_number] => 20090054627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'PROCESS FOR THE PURIFICATION OF IL-18 BINDING PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/250075 [patent_app_country] => US [patent_app_date] => 2008-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17582 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054627.pdf [firstpage_image] =>[orig_patent_app_number] => 12250075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6235003 [patent_doc_number] => 20100266707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'METHOD OF TREATING CACHEXIA WITH THE REMOVAL OR INACTIVATION OF MACROPHAGE INHIBITORY CYTOKINE-1' [patent_app_type] => utility [patent_app_number] => 12/734098 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7793 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266707.pdf [firstpage_image] =>[orig_patent_app_number] => 12734098 [rel_patent_id] =>[rel_patent_doc_number] =>)